ACTRN12619000003178
Completed
Phase 4
Bone remodelling and density of the pelvis following implantation of the delta TT acetabular cup in patients undergoing primary total hip replacement for hip arthritis
IMA Orthopeadics0 sites47 target enrollmentJanuary 8, 2019
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Hip replacement
- Sponsor
- IMA Orthopeadics
- Enrollment
- 47
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with rheumatoid or osteoarthritis of the hip who are candidates for a primary total hip replacement.
Exclusion Criteria
- •Patients with active infection, acute hip fracture, Patients who have had previous hip surgery. Patients with presence of malignancy in the hip joint area. Patient having surgery with other types of components. Patients who are mentally incompetent or unlikely to be compliant with the prescribed follow up evaluation schedule. Patients greater 125kg. Patients with a neuromuscular or concurrent illness which may affect their outcome.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting monoclonal antibody.An investigator-led, industry supported, multicentre, open-label, single treatment arm, prospective clinical trial. - Effects of B cell depletion on bone turnover in rheumatoid arthritis.EUCTR2010-020499-50-GBSouth Tees Hospitals NHS Foundation Trust46
Completed
Not Applicable
Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting antibodyISRCTN82317088South Tees Hospitals NHS Foundation Trust (UK)46
Completed
Not Applicable
Analyses of factors involved in bone remodeling and inflammation in Ankylosing Spondylitis (AS) patients undergoing etanercept therapyM45.00DRKS00004838Rheumazentrum Prof. Dr. med. G. Neeck56
Completed
Not Applicable
Effect on bone turnover and Bone Mineral Density (BMD) of low dose oral silicon as an adjunct to calcium/vitamin D3 in a randomised, placebo-controlled trialISRCTN57103074Bio Minerals N.V. (Belgium)184
Completed
Not Applicable
Bone Geometry and Muscle Density Changes in Postmenopausal Women and Breast Cancer Patients Prescribed AnastrozoleBreast CancerNCT00421447Hamilton Health Sciences Corporation58